Related Experiment Video
Updated: Aug 27, 2025

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The
Judith E Carroll1,2, Zev M Nakamura3, Brent J Small4
1Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA.
Chronic inflammation, indicated by C-reactive protein (CRP), may contribute to cognitive decline in older breast cancer survivors. Higher CRP levels were linked to poorer cognition, suggesting CRP testing
Area of Science:
- Oncology
- Neuroscience
- Immunology
Background:
- Cognitive impairment is a significant concern for older adults, particularly cancer survivors.
- Chronic inflammation, as measured by C-reactive protein (CRP), is implicated in various age-related conditions.
Purpose of the Study:
- To investigate the longitudinal association between C-reactive protein (CRP) levels and cognitive function in older breast cancer survivors.
- To compare these relationships between breast cancer survivors and age-matched non-cancer controls.
Main Methods:
- Longitudinal study of women aged 60+ years, including newly diagnosed breast cancer survivors (stage 0-III) and controls.
- Cognitive function assessed using Functional Assessment of Cancer Therapy-Cognitive Function and neuropsychological tests over 60 months.
- Mixed linear and random effect-lagged fluctuation models analyzed C-reactive protein (CRP) levels and their impact on subsequent cognition.
Main Results:
- Breast cancer survivors exhibited significantly higher C-reactive protein (CRP) levels compared to controls at multiple time points.
- Elevated CRP levels predicted diminished self-reported cognition in survivors, an effect not observed in controls.
- Survivors with higher CRP levels showed lower cognitive scores, with significant differences noted in specific neuropsychological tests like Trails B.
Conclusions:
- Longitudinal data suggest chronic inflammation, indicated by C-reactive protein (CRP), may contribute to cognitive difficulties in older breast cancer survivors.
- C-reactive protein (CRP) testing may hold clinical utility in monitoring and managing cognitive health during cancer survivorship care.
More Related Videos
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Cognitive Development During Adulthood
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...

